|
EI24 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.120100E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.377770E-02 |
| Normal-vs-Stage2 |
2.740600E-01 |
| Normal-vs-Stage3 |
1.312000E-01 |
| Normal-vs-Stage4 |
2.726400E-01 |
| Stage1-vs-Stage2 |
6.375000E-01 |
| Stage1-vs-Stage3 |
4.954000E-01 |
| Stage1-vs-Stage4 |
3.723000E-01 |
| Stage2-vs-Stage3 |
9.868200E-01 |
| Stage2-vs-Stage4 |
8.354600E-01 |
| Stage3-vs-Stage4 |
8.084000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.867500E-02 |
| Normal-vs-AfricanAmerican |
6.663500E-02 |
| Normal-vs-Asian |
2.719800E-03 |
| Caucasian-vs-AfricanAmerican |
6.177400E-01 |
| Caucasian-vs-Asian |
9.418200E-02 |
| AfricanAmerican-vs-Asian |
4.561000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.434210E-01 |
| Normal-vs-Female |
1.628470E-02 |
| Male-vs-Female |
5.207200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.016470E-02 |
| Normal-vs-Age(41-60Yrs) |
2.168000E-01 |
| Normal-vs-Age(61-80Yrs) |
6.924200E-02 |
| Normal-vs-Age(81-100Yrs) |
9.472200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.631600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.680200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.277400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.418600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.122000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.420800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.115200E-01 |
| Classical-VS-Follicular |
1.338430E-01 |
| Classical-VS-Other |
5.650600E-01 |
| Classical-VS-Normal |
4.976300E-03 |
| Tall-VS-Follicular |
1.197750E-01 |
| Tall-VS-Other |
3.941400E-01 |
| Tall-VS-Normal |
1.555580E-02 |
| Follicular-VS-Other |
9.722200E-01 |
| Follicular-VS-Normal |
5.065800E-01 |
| Other-VS-Normal |
6.689600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.448590E-01 |
| Normal-vs-N1 |
5.751700E-02 |
| N0-vs-N1 |
3.569400E-01 |
|
|
